Effect of C-terminal truncations on the aggregation propensity of A53E, a familial mutant of α-Synuclein: An Insilico Study

Airy Sanjeev, Venkata Satish Kumar Mattaparthi

Abstract


α-Synuclein, an intrinsically disordered protein, is well known for its role on the onset of Parkinson’s Disease (PD), a neurodegenerative disorder. In α-synuclein, several mutations have been known to cause genetic forms of PD. Recently a new familial mutant, A53E of α-synuclein was discovered in a family and found to accelerate the α-synuclein gene, SNCA. But the molecular details about the A53E α-synuclein aggregation were not well studied. It has been recently suggested that two C-terminally truncated α-synuclein (αS C-X): 120 and 123, along with the A53E mutation would cause a more aggressive pathology and an increase in aggregation. So here we demonstrate the effect of C-terminal truncations along with A53E mutation on the aggregation propensity of α-synuclein by comparing the conformational dynamics of A53E full length protein and its C-terminal truncations using molecular dynamics simulation methods. In A53E full length protein we observed stability to be more and also hydrophobic surface (NAC (non-amyloid β component) region), number of molecular interactions and interface area between monomeric units to be relatively less than αS C-X. Our findings in this study suggest that more the residues removed from the C-terminal along with A53E mutation have significant effect on the aggregation propensity of α-synuclein.


Keywords


Parkinson’s disease; amyloid; truncation; fibrillation; molecular dynamics

Full Text:

PDF PDF

References


Uversky, V.N. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. Journal of Biomolecular Structure and Dynamics, 2003, 21, 211-234. Doi: 10.1080/07391102.2003.10506918

Polymeropoulos, M.H.; Lavedan, C.; Leroy, E.; Ide, S.E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E.S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W.G.; Lazzarini, A.M.; Duvoisin, R.C.; Di Iorio, G.; Golbe, L.I.; Nussbaum, R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 1997, 276, 2045-2047. Doi: 10.1126/science.276.5321.2045

Spillantini, M.G.; Schmidt, M.L.; Lee, V.M.; Trojanowski, J.Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature, 1997, 388, 839-840. Doi: 10.1038/42166

Jin, H.; Kanthasamy, A.; Ghosh, A.; Yang, Y.; Anantharam, V.; Kanthasamy, A.G. α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. Journal of Neuroscience, 2011, 31, 2035-2051. Doi: 10.1523/jneurosci.5634-10.2011

Petrucelli, L.; Dickson, D.W. Neuropathology of Parkinson's disease: Molecular and Therapeutic Insights from Model Systems, 2008, 35-48, New York, NY: Elsevier Inc. Doi: 10.1016/b978-0-12-374028-1.00003-8

Shibasaki, Y.; Baillie, D.A.; St Clair, D.; Brookes, A.J. High resolution mapping of SNCA encoding alpha-synuclein, the non-A beta component of Alzheimer’s disease amyloid precursor, to human chromosome 4q21.3–>q22 by fluorescence in situ hybridization. Cytogenetics and Cell Genetics, 1995, 71, 54–55. Doi: 10.1159/000134061

Ross, O.A.; Braithwaite, A.T.; Farrer, M.J. Genetics of Parkinson's disease. Parkinson’s disease: Molecular and Therapeutic Insights from Model Systems, 2008, 9-25, New York, NY: Elsevier Inc. Doi: 10.1016/b978-0-12-374028-1.00002-6

Kanda, S.; Bishop, J.F.; Eglitis, M.A.; Yang, Y.; Mouradian, M.M. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience, 2000, 97, 279-284. Doi: 10.1016/s0306-4522(00)00077-4

Sharma, N.; Brandis, K.A.; Herrera, S.K.; Johnson, B.E.; Vaidya, T.; Shrestha, R.; Debburman, S.K. Alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress. Journal of Molecular Neuroscience, 2006, 28, 161-178. Doi: 10.1385/jmn:28:2:161

Volles, M.J.; Lansbury, P.T. Jr Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity.‎ Journal of Molecular Biology, 2007, 366, 1510-1522. Doi: 10.1016/j.jmb.2006.12.044

Ghosh, D.; Mondal, M.; Mohite, G.M.; Singh, P.K.; Ranjan, P.; Anoop, A.; Ghosh, S.; Jha, N.N.; Kumar, A.; Maji, S.K. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro. Biochemistry, 2013, 52, 6925-6927. Doi: 10.1021/bi400999d

Pasanen, P.; Myllykangas, L.; Siitonen, M.; Raunio, A.; Kaakkola, S.; Lyytinen, J.; Tienari, P.J.; Poyhonen, M.; Paetau, A. Novel α-synuclein mutation A53E associated with a typical multiple system atrophy and Parkinson's disease-type pathology. Neurobiology of Aging, 2014, 35, 2180.e1-5. Doi: 10.1016/j.neurobiolaging.2014.03.024

Dunn, A.; Graham, L. Creation of Novel alpha-Synuclein Mutation A53E Truncations 123 and 120 for Future Study in Budding Yeast. Lake Forest College: Eukaryon, 2015, 11.

Park, S.; Yoon, J.; Jang, S.; Lee, K.; Shin, S. The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study. Journal of Biomolecular Structure and Dynamics, 2015, 34, 376-383. Doi: 10.1080/07391102.2015.1033016

Kukulka, N. Uncovering the Mysteries of Alpha-Synuclein Natural Truncation Variants. Lake Forest College: Eukaryon, 2013, 9.

Hall, K.; Yang, S.; Sauchanka, O.; Spillantini, M.G.; Anichtchik, O. Behavioral deficits in transgenic mice expressing human truncated (1–120 amino acid) alpha-synuclein. Experimental Neurology, 2015, 264, 8–13. Doi: 10.1016/j.expneurol.2014.11.003

Games, D.; Valera, E.; Spencer, B.; Rockenstein, E.; Mante, M.; Adame, A.; Patrick, C.; Ubhi, K.; Nuber, S.; Sacayon, P.; Zago, W.; Seubert, P.; Barbour, R.; Schenk, D.; Masliah, E. Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson’s Disease-Like Models. Journal of Neuroscience, 2014, 34, 9441–9454. Doi: 10.1523/jneurosci.5314-13.2014

Liu, C.W.; Giasson, B.I.; Lewis, K.A.; Lee, V.M.; DeMartino, G.N.; Thomas, P.J. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: Implications for pathogenesis of Parkinson disease. Journal of Biological Chemistry, 2005, 280, 22670- 22678. Doi: 10.1074/jbc.m501508200

Ulusoy, A.; Febbraro, F.; Jensen, P.H.; Kirik, D.; Romero-Ramos, M. Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha- synuclein-induced pathology. European Journal of Neuroscience, 2010, 32, 409-422. Doi: 10.1111/j.1460-9568.2010.07284.x

Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The protein data bank. Nucleic Acids Research, 2000, 28, 235-242. Doi: 10.1093/nar/28.1.235

Guex, N.; Peitsch, M.C. SWISS-MODEL and the Swiss-pdb viewer: an environment for comparative protein modeling. Electrophoresis, 1997, 18, 2714-2723. Doi: 10.1002/elps.1150181505

Kaus, J.W.; Pierce, L.T.; Walker, R.C.; McCammon, J.A. Improving the Efficiency of Free Energy Calculations in the Amber Molecular Dynamics Package. Journal of Chemical Theory and Computation, 2012, 9: 4131-4139. Doi: 10.1021/ct400340s

Pearlman, D.A.; Case, D.A.; Caldwell, J.W.; Ross, W.S.; Cheatham, III T.E.; DeBolt, S.; Ferguson, D.; Seibel, G.; Kollman, P. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Computer Physics Communications, 1995, 91: 1-41. Doi: 10.1016/0010-4655(95)00041-d

Henriques, J.; Cragnell, C.; Skepo, M. Molecular Dynamics Simulations of Intrinsically Disordered Proteins: Force Field Evaluation and Comparison with Experiment. Journal of Chemical Theory and Computation, 2015, 11, 3420. Doi: 10.1021/ct501178z

Onufriev, A.; Bashford, D.; Case, D.A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins, 2004, 55: 383. Doi: 10.1002/prot.20033

Coskuner, O.; Wise-Scira, O. Structures and Free Energy Landscapes of the A53T Mutant-Type α Synuclein Protein and Impact of A53T Mutation on the Structures of the Wild-Type α Synuclein Protein with Dynamics. ACS Chemical Neuroscience, 2013, 4, 1101−1113. Doi: 10.1021/cn400041j

Ryckaert, J.P.; Ciccotti, G.; Berendsen, H.J. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal of Computational Physics, 1977, 23, 327-341. Doi: 10.1016/0021-9991(77)90098-5

Allen, M.P.; Tildesley, D.J. Computer Simulation of Liquids. Oxford, 1999, UK: Clarendon Press. Doi: 10.2307/2938686

Frenkel, D.; Smit, B. Understanding Molecular Simulation: From Algorithms to Applications. 2002, San Diego, CA: Academic Press. Doi: 10.1063/1.881812

Berendsen, H.J.C.; Postma, J.P.M.; van Gunsteren, W.F.; DiNola, A.; Haak, J.R. Molecular-Dynamics with Coupling to an External Bath. Journal of Chemical Physics, 1984, 81, 3684-3690. Doi: 10.1063/1.448118

Duhovny, D.; Nussinov, R.; Wolfson, H.J. Efficient unbound docking of rigid molecules, 2002, 185-200, Berlin Heidelberg: Springer-Verlag. Doi: 10.1007/3-540-45784-4_14

Zhang, C.; Vasmatzis, G.; Cornette, J.L.; DeLisi, C. Determination of atomic desolvation energies from the structures of crystallized proteins. Journal of Molecular Biology, 1997, 267, 707-726. Doi: 10.1006/jmbi.1996.0859

Laskowski, R.A. PDBsum: summaries and analyses of PDB structures. Nucleic Acids Research, 2001, 29, 221-222. Doi: 10.1093/nar/29.1.221

Daniel, R.R.; Thomas, E.C. III PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. Journal of Chemical Theory and Computation, 2013, 9, 3084-3095. Doi: 10.1021/ct400341p

Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera--a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 2004, 25, 1605-1612. Doi: 10.1002/jcc.20084

Humphrey, W.; Dalke, A.; Schulten, K. VMD: visual molecular dynamics. Journal of Molecular Graphics, 1996, 14, 33–38. Doi: 10.1016/0263-7855(96)00018-5

Krieger, E.; Koraimann, G.; Vriend, G. Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field. Proteins, 2002, 47, 393-402. Doi: 10.1002/prot.10104

Andricioaei, I.; Karplus, M. On the calculation of entropy from covariance matrices of the atomic fluctuations. J. Chem. Phys., 2001, 115, 6289. Doi: 10.1063/1.1401821

Yoon, J.; Park, J.; Jang, S.; Lee, K.; Shin, S. Conformational characteristics of unstructured peptides: alpha-synuclein. Journal of Biomolecular Structure and Dynamics, 2008, 25, 505-515. Doi: 10.1080/07391102.2008.10507197

Han, H.; Weinreb, P.H.; Lansbury, P.T. Jr The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Journal of Chemistry & Biology, 1995, 2, 163–169. Doi: 10.1016/1074-5521(95)90071-3

Kabsch, W.; Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 1983, 22, 2577-2637. Doi: 10.1002/bip.360221211